Copeland Capital Management, LLC Bristol Myers Squibb CO Transaction History

Copeland Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Jan 18, 2022	BUY	$59.17 - $69.31 $2,248 - $2,633	38 New	38 $2,000
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $2,248 - $2,633	-38 Closed	0 $0
Q2 2021 Jan 18, 2022	BUY	$61.91 - $67.42 $2,352 - $2,561	38 New	38 $3,000
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $2,352 - $2,561	-38 Closed	0 $0
Q1 2021 Jan 18, 2022	BUY	$59.34 - $66.74 $2,254 - $2,536	38 New	38 $2,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $2,254 - $2,536	-38 Closed	0 $0
Q4 2020 Jan 18, 2022	BUY	$57.74 - $65.43 $2,194 - $2,486	38 New	38 $2,000
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $2,194 - $2,486	-38 Closed	0 $0
Q3 2020 Jan 18, 2022	BUY	$57.43 - $63.64 $2,182 - $2,418	38 New	38 $2,000
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $2,182 - $2,418	-38 Closed	0 $0
Q2 2020 Jan 18, 2022	BUY	$54.82 - $64.09 $2,083 - $2,435	38 New	38 $2,000
Q2 2020 Jul 30, 2020	SELL	$54.82 - $64.09 $2,083 - $2,435	-38 Closed	0 $0
Q1 2020 Jan 18, 2022	BUY	$46.4 - $67.43 $1,763 - $2,562	38 New	38 $2,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Copeland Capital Management, LLC with notifications on news.